Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal

References

• Andari, E., F. C. Schneider, R. Mottolese, P. Vindras, and A. Sirigu. 2014. Oxytocin’s fingerprint in personality traits and regional brain volume. Cerebral Cortex 24 (2):479–86. doi:10.1093/cercor/bhs328.
   PubMed Web of Science ®Google Scholar
• APA (American Psychiatric Association). 2013. DSM 5: Fifth edition of the diagnostic and statistical manual of mental disorders of the American Psychiatric Association. Arlington, VA: American Psychiatric Association Publishing.
   Google Scholar
• Baracz, S. J., L. M. Parker, A. S. Suraev, N. A. Everett, A. K. Goodchild, I. S. McGregor, and J. L. Cornish. 2015. Chronic methamphetamine self‐administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and subthalamic nucleus of the rat. Journal of Neuroendocrinology 28 (4). doi:10.1111/jne.12337.
   Web of Science ®Google Scholar
• Batel, P., C. Reynaud-Maurupt, P. Lavignasse, M. V. Constant, P. Kopp, J. J. Jourdain, B. Videau, A. Mucchielli, B. Riff, and W. Lowenstein. 2004. Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy: A study of 1085 opiate addicts. Presse Med 33 (18 Suppl):5–9. doi:10.1016/S0755-4982(04)72375-1.
   PubMed Web of Science ®Google Scholar
• Blodgett, J. C., N. C. Maisel, I. L. Fuh, P. L. Wilbourne, and J. W. Finney. 2014. How effective is continuing care for substance use disorders? A meta-analytic review. Journal of Substance Abuse Treatment 46 (2):87–97. doi:10.1016/j.jsat.2013.08.022.
   PubMed Web of Science ®Google Scholar
• Bowen, M. T., D. S. Carson, A. Spiro, J. C. Arnold, and I. S. McGregor. 2011. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. Plos One 6 (11):e27237–e27237. doi:10.1371/journal.pone.0027237.
   PubMed Web of Science ®Google Scholar
• Brown, C. H., and J. A. Russell. 2004. Cellular mechanisms underlying neuronal excitability during morphine withdrawal in physical dependence: Lessons from the magnocellular oxytocin system. Stress: The International Journal on the Biology of Stress 7 (2):97–107. doi:10.1080/10253890410001727776.
   PubMed Web of Science ®Google Scholar
• Brown, C. H., J. A. Russell, and G. Leng. 2000. Opioid modulation of magnocellular neurosecretory cell activity. Neuroscience Research 36 (2):97–120. doi:10.1016/S0168-0102(99)00121-2.
   PubMed Web of Science ®Google Scholar
• Brown, C. H., J. E. Stern, K. L. M. Jackson, P. M. Bull, G. Leng, and J. A. Russell. 2005. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine‐dependent rats. European Journal of Neuroscience 21 (2):501–12. doi:10.1111/j.1460-9568.2005.03885.x.
   PubMed Web of Science ®Google Scholar
• Buisman-Pijlman, F. T., N. M. Sumracki, J. J. Gordon, P. R. Hull, C. S. Carter, and M. Tops. 2014. Individual differences underlying susceptibility to addiction: Role for the endogenous oxytocin system. Pharmacology Biochemistry and Behavior 119:22–38. doi:10.1016/j.pbb.2013.09.005.
   PubMed Web of Science ®Google Scholar
• Bull, P. M., J. A. Russell, V. Scott, and C. H. Brown. 2011. Apamin increases post-spike excitability of supraoptic nucleus neurons in anaesthetized morphine-naïve rats and morphine-dependent rats: Consequences for morphine withdrawal excitation. Experimental Brain Research 212 (4):517–28. doi:10.1007/s00221-011-2759-z.
   PubMed Web of Science ®Google Scholar
• Burkett, J. P., and L. J. Young. 2012. The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology 224 (1):1–26.
   PubMed Web of Science ®Google Scholar
• Carson, D. S., A. J. Guastella, E. R. Taylor, and I. S. McGregor. 2013. A brief history of oxytocin and its role in modulating psychostimulant effects. Journal of Psychopharmacology 27 (3):231–47. doi:10.1177/0269881112473788.
   PubMed Web of Science ®Google Scholar
• Carson, D. S., G. E. Hunt, A. J. Guastella, L. Barber, J. L. Cornish, J. C. Arnold, A. A. Boucher, and I. S. McGregor. 2010. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology 15 (4):448–63. doi:10.1111/adb.2010.15.issue-4.
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse Treatment. 2004. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Churchland, P.S., and P. Winkielman. 2012. Modulating social behavior with oxytocin: How does it work? What does it mean? Hormones & Behaviour 61:392–99.
   Google Scholar
• Coombes, J. E., I. C. A. F. Robinson, F. A. Antoni, and J. A. Russell. 1991. Release of oxytocin into blood and into cerebrospinal fluid induced by naloxone in anaesthetized morphine‐dependent rats: The role of the paraventricular nucleus. Journal of Neuroendocrinology 3 (5):551–61. doi:10.1111/jne.1991.3.issue-5.
   PubMed Web of Science ®Google Scholar
• Dabrowska, J., R. Hazra, T. H. Ahern, J.-D. Guo, A. J. McDonald, F. Mascagni, J. F. Muller, L. J. Young, and D. G. Rainnie. 2011. Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect. Psychoneuroendocrinology 36 (9):1312–26. doi:10.1016/j.psyneuen.2011.03.003.
   PubMed Web of Science ®Google Scholar
• Flanagan, J. C., N. L. Baker, A. L. McRae-Clark, K. T. Brady, and M. M. Moran-Santa Maria. 2015. Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence. Psychiatry Research 229:94–100. doi:10.1016/j.psychres.2015.07.064.
   PubMed Web of Science ®Google Scholar
• Ford, L. K., and P. Zarate. 2010. Closing the gaps: The impact of inpatient detoxification and continuity of care on client outcomes. Journal of Psychoactive Drugs Suppl 42:303–14. doi:10.1080/02791072.2010.10400554.
   Google Scholar
• Franken, I. H., and V. M. Hendriks. 1999. Predicting outcome of inpatient detoxification of substance abusers. Psychiatric Services 50 (6):813–17. doi:10.1176/ps.50.6.813.
   PubMed Web of Science ®Google Scholar
• Georgiou, P., P. Zanos, M. Ehteramyan, S. Hourani, I. Kitchen, R. Maldonado, and A. Bailey. 2015. Differential regulation of mGlu 5 R and ΜOPr by priming- and cue-induced reinstatement of cocaine-seeking behaviour in mice. Addiction Biology 20 (5):902–12. doi:10.1111/adb.12208.
   PubMed Web of Science ®Google Scholar
• Georgiou, P., P. Zanos, J.-A. Garcia-Carmona, S. Hourani, I. Kitchen, M.-L. Laorden, and A. Bailey. 2016a. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype. Neuropharmacology 105:520–32. doi:10.1016/j.neuropharm.2016.02.012.
   PubMed Web of Science ®Google Scholar
• Georgiou, P., P. Zanos, S. Hourani, I. Kitchen, and A. Bailey. 2016b. Cocaine abstinence induces emotional impairment and brain region-specific upregulation of the oxytocin receptor binding. European Journal of Neuroscience 44:2446–54. doi:10.1111/ejn.13348.
   PubMed Web of Science ®Google Scholar
• Hakansson, A., and E. Hallén. 2014. Predictors of dropout from inpatient opioid detoxification with buprenorphine: A chart review. Journal of Addiction 2014:1–5. doi:10.1155/2014/965267.
   Google Scholar
• Hamilton, M. 1959. The assessment of anxiety states by rating. British Journal of Medical Psychology 32:50–55. doi:10.1111/papt.1959.32.issue-1.
   PubMed Web of Science ®Google Scholar
• Hamilton, M. 1960. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 23:56–62. doi:10.1136/jnnp.23.1.56.
   PubMed Web of Science ®Google Scholar
• Hendricks, L. E., J. A. Bayton, J. L. Collins, C. B. Mathura, S. R. McMillan, and T. A. Montgomery. 1983. The NIMH diagnostic interview schedule: A test of its validity in a population of Black adults. Journal of the National Medical Association 75 (7):667–71.
   PubMed Web of Science ®Google Scholar
• Hoge, E. A., E. A. Lawson, C. A. Metcalf, A. Keshaviah, P. J. Zak, M. H. Pollack, and N. M. Simon. 2012. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depression and Anxiety 29 (11):924–30. doi:10.1002/da.2012.29.issue-11.
   PubMed Web of Science ®Google Scholar
• Jesova, D., E. Juránková, A. Mosnárová, and M. Kriška. 1996. Neuroendocrine response during stress with relation to gender differences. Acta Neurobiologiae Experimentalis 56 (3):779–85.
   PubMed Web of Science ®Google Scholar
• Johnston, J., N. Lintzeris, D. J. Allsop, A. Suraev, J. Booth, D. S. Carson, D. Helliwell, A. Winstock, and I. S. McGregor. 2014. Lithium carbonate in the management of cannabis withdrawal: A randomized placebo-controlled trial in an inpatient setting. Psychopharmacology 231 (24):4623–36. doi:10.1007/s00213-014-3611-5.
   PubMed Web of Science ®Google Scholar
• Katz, E. C., B. S. Brown, R. P. Schwartz, K. E. O’Grady, S. D. King, and D. Gandhi. 2011. Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role induction. Drug Alcohol and Dependence 117 (1):24–30. doi:10.1016/j.drugalcdep.2010.12.024.
   PubMed Web of Science ®Google Scholar
• Kenne, D. R., A. P. Boros, and R. L. Fischbein. 2010. Characteristics of opiate users leaving detoxification treatment against medical advice. Journal of Addictive Diseases 29 (3):383–94. doi:10.1080/10550887.2010.489452.
   PubMed Web of Science ®Google Scholar
• Kovács, G. L., M. Vecsernyès, F. Laczi, M. Faludi, G. Telegdy, and F. A. Lászlò. 1985. Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus. Brain Research 328 (1):158–60. doi:10.1016/0006-8993(85)91336-8.
   PubMed Web of Science ®Google Scholar
• Kovács, G. L., F. Laczi, M. Vecsernyes, K. Hódi, G. Telegdy, and F. A. László. 1987. Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence. Experimental Brain Research 65 (2):307–11. doi:10.1007/BF00236302.
   PubMed Web of Science ®Google Scholar
• Kovács, G. L., Z. Sarnyai, and G. Szabó. 1998. Oxytocin and addiction: A review. Psychoneuroendocrinology 23 (8):945–62. doi:10.1016/S0306-4530(98)00064-X.
   PubMed Web of Science ®Google Scholar
• Kovács, G. L., and G. Telegdy. 1988. Hypothalamo-neurohypophyseal neuropeptides and experimental drug addiction. Brain Research Bulletin 20 (6):893–95. doi:10.1016/0361-9230(88)90107-4.
   PubMed Web of Science ®Google Scholar
• Landgraf, R., and I. D. Neumann. 2004. Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology 25 (3–4):150–76. doi:10.1016/j.yfrne.2004.05.001.
   PubMed Web of Science ®Google Scholar
• Landry, M., M. Frasier, Z. Chen, L. D. Van De Kar, Y. Zhang, F. Garcia, and G. Battaglia. 2005. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin. Synapse 58 (2):102–09. doi:10.1002.
   PubMed Web of Science ®Google Scholar
• Laorden, M. L., M. V. Milanés, M. Chapleur-Château, and A. Burlet. 1998. Changes in oxytocin content in rat brain during morphine withdrawal. Neuropeptides 32 (1):67–71. doi:10.1016/S0143-4179(98)90019-1.
   PubMed Web of Science ®Google Scholar
• Leckman, J. F. 2011. Variations in maternal behavior—oxytocin and reward pathways—peripheral measures matter? Neuropsychopharmacology 36 (13):2587–88. doi:10.1038/npp.2011.201.
   PubMed Web of Science ®Google Scholar
• Lee, M. R., M. Glassman, B. King-Casas, D. L. Kelly, E. A. Stein, J. Schroeder, and B. J. Salmeron. 2014. Complexity of oxytocin’s effects in a chronic cocaine dependent population. European Neuropsychopharmacology 24:1483–91. doi:10.1016/j.euroneuro.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Lee, M. R., M. C. Rohn, G. Tanda, and L. Leggio. 2016. Targeting the oxytocin system to treat addictive disorders: Rationale and progress to date. CNS Drugs 30 (2):109–23. doi:10.1007/s40263-016-0313-z.
   PubMed Web of Science ®Google Scholar
• Leng, G., and M. Ludwig. 2016. Intranasal oxytocin: Myths and delusions. Biological Psychiatry 79 (3):243–50. doi:10.1016/j.biopsych.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Leng, G., and N. Sabatier. 2016. Measuring oxytocin and vasopressin: Bioassays, immunoassays and random numbers. Journal of Neuroendocrinology 28. doi:10.1111/jne.12413.
   Web of Science ®Google Scholar
• Li, J.-H., Z.-D. You, Z.-Y. Chen, C.-Y. Song, and C.-L. Lu. 2001. Chronic morphine treatment inhibits oxytocin release from the supraoptic nucleus slices of rats. Neuroscience Letters 300 (1):54–58. doi:10.1016/S0304-3940(01)01540-3.
   PubMed Web of Science ®Google Scholar
• Lin, S.-H., L.-T. Lee, H. C. Tsai, K. C. Chen, W. T. Chen, I. H. Lee, R.-B. Lu, P. S. Chen, and Y. K. Yang. 2015. Association between blood level of plasma oxytocin and novelty seeking among methadone-maintained heroin users. Neuropsychobiology 71 (2):65–69. doi:10.1159/000371637.
   PubMed Web of Science ®Google Scholar
• Ludwig, M., and G. Leng. 2006. Dendritic peptide release and peptide-dependent behaviours. Nature Reviews Neuroscience 7 (2):126–36. doi:10.1038/nrn1845.
   PubMed Web of Science ®Google Scholar
• Marchesi, C., P. Chiodera, E. Brusamonti, R. Volpi, and V. Coiro. 1997. Abnormal plasma oxytocin and β-endorphin levels in alcoholics after short and long term abstinence. Progress in Neuro-Psychopharmacology and Biological Psychiatry 21 (5):797–807. doi:10.1016/S0278-5846(97)00080-8.
   PubMed Web of Science ®Google Scholar
• McGregor, I. S., P. D. Callaghan, and G. E. Hunt. 2008. From ultrasocial to antisocial: A role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use? British Journal of Pharmacology 154 (2):358–68. doi:10.1038/bjp.2008.132.
   PubMed Web of Science ®Google Scholar
• McRae-Clark, A. L., N. L. Baker, M. M. Maria, and K. T. Brady. 2013. Effect of oxytocin on craving and stress response in marijuana-dependent individuals: A pilot study. Psychopharmacology 228 (4):623–31. doi:10.1007/s00213-013-3062-4.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., B. Larance, L. Degenhardt, L. Gowing, C. Kehler, and N. Lintzeris. 2016. Opioid agonist treatment for pharmaceutical opioid dependent people. The Cochrane Database of Systematic Reviews 9 (5):CD011117.
   Google Scholar
• Nosyk, B., L. Li, E. Evans, D. Urada, D. Huang, E. Wood, R. Rawson, and Y. Hser. 2014. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, US: 1991–2012. Drug Alcohol and Dependence 143:149–57. doi:10.1016/j.drugalcdep.2014.07.020.
   PubMed Web of Science ®Google Scholar
• O’Shea, M., I. S. McGregor, and P. E. Mallet. 2006. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology 20 (5):611–21. doi:10.1177/0269881106065188.
   PubMed Web of Science ®Google Scholar
• Pedersen, C. A., K. L. Smedley, J. Leserman, L. F. Jarskog, S. W. Rau, A. Kampov‐Polevoi, R. L. Casey, T. Fender, and J. C. Garbutt. 2013. Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcoholism: Clinical and Experimental Research 37 (3):484–89. doi:10.1111/acer.2013.37.issue-3.
   PubMed Web of Science ®Google Scholar
• Renzelli, C. M., and N. A. Capretto. 2006. Less pain, more gain: Buprenorphine-naloxone and patient retention in treatment. Journal of Addictive Diseases 25 (3):97–104. doi:10.1300/J069v25n03_12.
   PubMed Web of Science ®Google Scholar
• Russell, J. A., I. Neumann, and R. Landgraf. 1992. Oxytocin and vasopressin release in discrete brain areas after naloxone in morphine-tolerant and-dependent anesthetized rats: Push-pull perfusion study. The Journal of Neuroscience 12 (3):1024–32.
   PubMed Web of Science ®Google Scholar
• Russell, J. A., K. M. Pumford, and R. J. Bicknell. 1992. Contribution of the region anterior and ventral to the third ventricle to opiate withdrawal excitation of oxytocin secretion. Neuroendocrinology 55 (2):183–92. doi:10.1159/000126113.
   PubMed Web of Science ®Google Scholar
• Sarnyai, Z. 1998. Oxytocin and neuroadaptation to cocaine. Progress in Brain Research 119:449–66.
   PubMed Web of Science ®Google Scholar
• Sarnyai, Z. 2011. Oxytocin as a potential mediator and modulator of drug addiction. Addiction Biology 16 (2):199–201. doi:10.1111/adb.2011.16.issue-2.
   PubMed Web of Science ®Google Scholar
• Sarnyai, Z., and G. L. Kovács. 1994. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 19 (1):85–117. doi:10.1016/0306-4530(94)90062-0.
   PubMed Web of Science ®Google Scholar
• Sarnyai, Z., M. Vecsernyés, F. Laczi, É. Bíró, G. Szabó, and G. L. Kovács. 1992. Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats. Neuropeptides 23 (1):27–31. doi:10.1016/0143-4179(92)90006-I.
   PubMed Web of Science ®Google Scholar
• Scantamburlo, G., M. Hansenne, S. Fuchs, W. Pitchot, P. Maréchal, C. Pequeux, M. Ansseau, and J. J. Legros. 2007. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32 (4):407–10. doi:10.1016/j.psyneuen.2007.01.009.
   PubMed Web of Science ®Google Scholar
• Sees, K. L., K. L. Delucchi, C. Masson, A. Rosen, H. W. Clark, H. Robillard, P. Banys, and S. M. Hall. 2000. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. JAMA 283 (10):1303–10. doi:10.1001/jama.283.10.1303.
   PubMed Web of Science ®Google Scholar
• Sheward, W. J., J. E. Coombes, R. J. Bicknell, G. Fink, and J. A. Russell. 1990. Release of oxytocin but not corticotrophin-releasing factor-41 into rat hypophysial portal vessel blood can be made opiate dependent. Journal of Endocrinology 124 (1):141–50. doi:10.1677/joe.0.1240141.
   PubMed Web of Science ®Google Scholar
• Silva, S. M., M. D. Madeira, C. Ruela, and M. M. Paula-Barbosa. 2002. Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. Brain Research 925 (1):76–88. doi:10.1016/S0006-8993(01)03261-9.
   PubMed Web of Science ®Google Scholar
• Smyth, B. P., J. Barry, E. Keenan, and K. Ducray. 2010. Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal 103 (6):176–79.
   PubMedGoogle Scholar
• Specka, M., A. Buchholz, T. Kuhlmann, F. Rist, and N. Scherbaum. 2011. Prediction of the outcome of inpatient opiate detoxification treatment: Results from a multicenter study. European Addiction Research 17 (4):178–84. doi:10.1159/000324873.
   PubMed Web of Science ®Google Scholar
• Theodosis, D. T. 2002. Oxytocin-secreting neurons: A physiological model of morphological neuronal and glial plasticity in the adult hypothalamus. Frontiers in Neuroendocrinology 23:101–35. doi:10.1006/frne.2001.0226.
   PubMed Web of Science ®Google Scholar
• Timko, C., M. Below, N. R. Schultz, D. Brief, and M. A. Cucciare. 2015. Patient and program factors that bridge the detoxification-treatment gap: A structured evidence review. Journal of Substance Abuse Treatment 52:31–39. doi:10.1016/j.jsat.2014.11.009.
   PubMed Web of Science ®Google Scholar
• Tops, M., J. M. Van Peer, J. Korf, A. A. Wijers, and D. M. Tucker. 2007. Anxiety, cortisol, and attachment predict plasma oxytocin. Psychophysiology 44 (3):444–49. doi:10.1111/psyp.2007.44.issue-3.
   PubMed Web of Science ®Google Scholar
• Uvnäs-Moberg, K. 1998. Antistress pattern induced by oxytocin. Physiology 13 (1):22–25.
   Google Scholar
• Uvnäs-Moberg, K., E. Björkstrand, V. Hillegaart, and S. Ahlenius. 1999. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology 142 (1):95–101. doi:10.1007/s002130050867.
   PubMed Web of Science ®Google Scholar
• Weisman, O., O. Zagoory-Sharon, I. Schneiderman, I. Gordon, and R. Feldman. 2013. Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety. Psychoneuroendocrinology 38 (5):694–701. doi:10.1016/j.psyneuen.2012.08.011.
   PubMed Web of Science ®Google Scholar
• Wesson, D. R., and W. Ling. 2003. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 35 (2):253–59. doi:10.1080/02791072.2003.10400007.
   PubMed Web of Science ®Google Scholar
• Wewers, M. E., and N. K. Lowe. 1990. A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing & Health 13:227–36. doi:10.1002/(ISSN)1098-240X.
   PubMed Web of Science ®Google Scholar
• Windle, R. J., N. Shanks, S. L. Lightman, and C. D. Ingram. 1997. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138 (7):2829–34.
   PubMed Web of Science ®Google Scholar
• Woolley, J. D., P. A. Arcuni, C. S. Stauffer, D. Fulford, D. S. Carson, S. Batki, and S. Vinogradov. 2016. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: A pilot study. Psychopharmacology (Berl) 233 (13):2571–80. doi:10.1007/s00213-016-4308-8.
   PubMed Web of Science ®Google Scholar
• Wotjak, C. T., J. Ganster, G. Kohl, F. Holsboer, R. Landgraf, and M. Engelmann. 1998. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons. Neuroscience 85 (4):1209–22.
   Web of Science ®Google Scholar
• Wotjak, C. T., T. Naruo, S. Muraoka, R. Simchen, R. Landgraf, and M. Engelmann. 2001. Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus. European Journal of Neuroscience 13 (12):2273–81.
   Web of Science ®Google Scholar
• Zanos, P., P. Georgiou, S. R. Wright, S. M. Hourani, I. Kitchen, R. Winsky-Sommerer, and A. Bailey. 2014. The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology 39 (4):855–65. doi:10.1038/npp.2013.285.
   PubMed Web of Science ®Google Scholar
• Zanos, P., P. Georgiou, A. Metaxas, I. Kitchen, R. Winsky-Sommerer, and A. Bailey. 2015. Region-specific up-regulation of oxytocin receptor binding in the brain of mice following chronic nicotine administration. Neuroscience Letters 600:33–37. doi:10.1016/j.neulet.2015.05.054.
   PubMed Web of Science ®Google Scholar